Stay updated on Metoclopramide Nasal Spray in Diabetic Gastroparesis Clinical Trial
Sign up to get notified when there's something new on the Metoclopramide Nasal Spray in Diabetic Gastroparesis Clinical Trial page.

Latest updates to the Metoclopramide Nasal Spray in Diabetic Gastroparesis Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNo visible additions or deletions between the two screenshots; page content appears unchanged.SummaryDifference0.0%

- Check34 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-status notice and Revision: v3.4.1.SummaryDifference0.3%

- Check41 days agoChange DetectedA site-wide notice about potential delays due to government funding and the NIH Clinical Center's operating status was added. The page now shows Revision: v3.4.1, replacing Revision: v3.4.0.SummaryDifference0.3%

- Check48 days agoChange DetectedUI updates add a glossary toggle and new labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and introduce a revision note 'Revision: v3.4.0' to replace the older labels and version.SummaryDifference0.2%

- Check84 days agoChange DetectedThe Locations section now shows a full state-by-state list (Alabama through Wisconsin) and the page revision is updated to v3.3.3. The previous state-location blocks and the HHS Vulnerability Disclosure link were removed.SummaryDifference2%

Stay in the know with updates to Metoclopramide Nasal Spray in Diabetic Gastroparesis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Metoclopramide Nasal Spray in Diabetic Gastroparesis Clinical Trial page.